Alfonso Soto‐Moreno

1.1k total citations
43 papers, 747 citations indexed

About

Alfonso Soto‐Moreno is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Alfonso Soto‐Moreno has authored 43 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Alfonso Soto‐Moreno's work include Pituitary Gland Disorders and Treatments (32 papers), Growth Hormone and Insulin-like Growth Factors (17 papers) and Neuroendocrine Tumor Research Advances (10 papers). Alfonso Soto‐Moreno is often cited by papers focused on Pituitary Gland Disorders and Treatments (32 papers), Growth Hormone and Insulin-like Growth Factors (17 papers) and Neuroendocrine Tumor Research Advances (10 papers). Alfonso Soto‐Moreno collaborates with scholars based in Spain, United States and United Kingdom. Alfonso Soto‐Moreno's co-authors include Eva Venegas‐Moreno, Raúl M. Luque, Justo P. Castaño, Ainara Madrazo‐Atutxa, Alfonso Leal‐Cerro, María A. Gálvez, Alejandro Ibáñez‐Costa, David A. Cano, Manuel D. Gahete and Mari C. Vázquez‐Borrego and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Alfonso Soto‐Moreno

38 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Soto‐Moreno Spain 16 546 238 163 149 106 43 747
Eva Venegas‐Moreno Spain 15 482 0.9× 227 1.0× 147 0.9× 140 0.9× 97 0.9× 34 656
Nigel Mendoza United Kingdom 16 323 0.6× 173 0.7× 181 1.1× 94 0.6× 167 1.6× 36 628
Harvinder Chahal United Kingdom 17 603 1.1× 162 0.7× 461 2.8× 209 1.4× 122 1.2× 37 977
María A. Tichomirowa Belgium 14 1.1k 2.0× 287 1.2× 549 3.4× 189 1.3× 303 2.9× 25 1.3k
Nicole Moayeri United States 5 509 0.9× 117 0.5× 204 1.3× 93 0.6× 66 0.6× 7 673
E. Ciccarelli Italy 20 1.1k 2.1× 276 1.2× 543 3.3× 206 1.4× 130 1.2× 51 1.4k
María A. Gálvez Spain 11 353 0.6× 127 0.5× 97 0.6× 54 0.4× 63 0.6× 16 416
Laurence Guignat France 21 1.1k 1.9× 86 0.4× 628 3.9× 129 0.9× 65 0.6× 49 1.3k
G. Oppizzi Italy 19 902 1.7× 189 0.8× 365 2.2× 76 0.5× 106 1.0× 37 1.0k
Mary P. Gillam United States 10 744 1.4× 90 0.4× 424 2.6× 162 1.1× 82 0.8× 11 931

Countries citing papers authored by Alfonso Soto‐Moreno

Since Specialization
Citations

This map shows the geographic impact of Alfonso Soto‐Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Soto‐Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Soto‐Moreno more than expected).

Fields of papers citing papers by Alfonso Soto‐Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Soto‐Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Soto‐Moreno. The network helps show where Alfonso Soto‐Moreno may publish in the future.

Co-authorship network of co-authors of Alfonso Soto‐Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Soto‐Moreno. A scholar is included among the top collaborators of Alfonso Soto‐Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Soto‐Moreno. Alfonso Soto‐Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venegas‐Moreno, Eva, Elena de Dios, Juan Pedro Martı́nez-Barberá, et al.. (2024). Conditional Pten inactivation in pituitary results in sex-specific prolactinoma formation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167543–167543.
2.
Piñar-Gutiérrez, Ana, et al.. (2022). Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice. Journal of Diabetes Research. 2022. 1–16. 6 indexed citations
3.
Martínez-Ortega, Antonio Jesús, et al.. (2022). Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia. Journal of Clinical Medicine. 11(4). 1039–1039. 9 indexed citations
4.
Remón-Ruiz, Pablo, et al.. (2022). Cardiometabolic and Nutritional Morbidities of a Large, Adult, PKU Cohort from Andalusia. Nutrients. 14(6). 1311–1311. 15 indexed citations
5.
Remón-Ruiz, Pablo, Eva Venegas‐Moreno, M. Alonso Garcìa, et al.. (2021). A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report. Frontiers in Endocrinology. 12. 784889–784889. 3 indexed citations
6.
Vázquez‐Borrego, Mari C., Antonio C. Fuentes-Fayos, Aura D. Herrera‐Martínez, et al.. (2020). Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors. Neuroendocrinology. 110(11-12). 1028–1041. 15 indexed citations
7.
Vázquez‐Borrego, Mari C., Antonio C. Fuentes-Fayos, Eva Venegas‐Moreno, et al.. (2019). Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features. Cancers. 11(10). 1439–1439. 30 indexed citations
8.
García‐Martínez, Araceli, David A. Cano, Joan Gil, et al.. (2019). Why don’t corticotroph tumors always produce Cushing’s disease?. European Journal of Endocrinology. 181(3). 351–361. 7 indexed citations
9.
Venegas‐Moreno, Eva, Elena de Dios, Mari C. Vázquez‐Borrego, et al.. (2019). E‐cadherin expression is associated with somatostatin analogue response in acromegaly. Journal of Cellular and Molecular Medicine. 23(5). 3088–3096. 36 indexed citations
10.
Vázquez‐Borrego, Mari C., Antonio C. Fuentes-Fayos, Aura D. Herrera‐Martínez, et al.. (2019). Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms. The Journal of Clinical Endocrinology & Metabolism. 104(8). 3501–3513. 32 indexed citations
11.
Ibáñez‐Costa, Alejandro, Laura M. López‐Sánchez, Manuel D. Gahete, et al.. (2017). BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas. Scientific Reports. 7(1). 42002–42002. 27 indexed citations
12.
Ibáñez‐Costa, Alejandro, Esther Rivero‐Cortés, Mari C. Vázquez‐Borrego, et al.. (2016). Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro. Journal of Endocrinology. 231(2). 135–145. 63 indexed citations
13.
Martin‐Rodríguez, Juan Francisco, Alejandro Ibáñez‐Costa, Marcin Balcerzyk, et al.. (2015). Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly. Scientific Reports. 5(1). 16298–16298. 10 indexed citations
14.
Luque, Raúl M., Alejandro Ibáñez‐Costa, Leonardo Vieira Neto, et al.. (2015). Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas. Cancer Letters. 359(2). 299–306. 69 indexed citations
15.
Cano, David A., Alfonso Soto‐Moreno, & Alfonso Leal‐Cerro. (2014). Genetically Engineered Mouse Models of Pituitary Tumors. Frontiers in Oncology. 4. 203–203. 7 indexed citations
16.
Martin‐Rodríguez, Juan Francisco, Ainara Madrazo‐Atutxa, Eva Venegas‐Moreno, et al.. (2013). Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly. PLoS ONE. 8(4). e60041–e60041. 37 indexed citations
17.
Leal‐Cerro, Alfonso, Juan Francisco Martin‐Rodríguez, Alejandro Ibáñez‐Costa, et al.. (2013). Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease. Endocrinología y Nutrición. 61(2). 69–76. 6 indexed citations
18.
19.
León‐Justel, Antonio, et al.. (2011). Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism. Clinica Chimica Acta. 412(23-24). 2248–2253. 11 indexed citations
20.
León‐Carrión, José, Alfonso Soto‐Moreno, A Pumar, et al.. (2008). A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clinical Endocrinology. 70(2). 192–200. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Venegas‐Moreno Breakdown of academic impact, for papers by Nigel Mendoza Breakdown of academic impact, for papers by Harvinder Chahal Breakdown of academic impact, for papers by María A. Tichomirowa Breakdown of academic impact, for papers by Nicole Moayeri Breakdown of academic impact, for papers by E. Ciccarelli Breakdown of academic impact, for papers by María A. Gálvez Breakdown of academic impact, for papers by Laurence Guignat Breakdown of academic impact, for papers by G. Oppizzi Breakdown of academic impact, for papers by Mary P. Gillam
Rankless by CCL
2026